Drug Developer Invests $243 Million to Add Manufacturing Space, Offices and Equipment
Monday, August 8, 2016
Source: Albany Business Review
Drug maker Regeneron Pharmaceuticals invested $243 million over the past six months to increase manufacturing capacity and add office space as sales continue to grow.
The Tarrytown, New York company employs more than 1,400 people in East Greenbush where the company makes drugs for treating eye disease and high cholesterol.